PharmaSea – Increasing Value and Flow in the Marine Biodiscovery Pipeline

PharmaSea brings together a broad international, interdisciplinary consortium of 24 partners from 13 countries from industry, academia and non-profit organisations with world-leading researchers in the areas of marine genomics, biosynthesis and chemical structure analysis as well as legal experts.

The PharmaSea project focuses on biodiscovery research and the development and commercialisation of new substances from marine organisms. Its primary goal is to collect samples from some of the hottest, deepest and coldest places on the planet. These samples will be screened to uncover marine microbes and new bioactive compounds to evaluate their potential as novel drug leads, antibiotics or ingredients for nutrition or cosmetic applications. PharmaSea is funded by the European Union under its FP7 programme.

Project period: 2012-2017
Finances: EU FP7 project
Amount: 9,5 mill EUR
Webpage: www.pharma-sea.eu